Search for: "TEVA PHARMACEUTICALS USA, INC." Results 21 - 40 of 403
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Oct 2014, 9:59 pm by Patent Docs
By Andrew Williams -- On Wednesday, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
17 Oct 2018, 7:49 pm by Brian Craig
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
5 Mar 2019, 7:28 am by Eric L. Young
District Judge Colleen McMahon ruled on February 27th that a False Claims Act suit brought by two former employees of Teva Pharmaceuticals USA, Inc. will proceed to a trial on the merits. [read post]
31 Mar 2014, 8:47 pm by Patent Docs
By Andrew Williams -- Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
7 Jun 2018, 4:59 pm by Patent Docs
Ltd.; Teva Pharmaceuticals International GMGH; and Teva Pharmaceuticals USA, Inc. [read post]
13 Oct 2014, 8:46 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. et al. v. [read post]
11 Sep 2020, 7:06 am by Peter Briccetti
The U.S. government filed a False Claims Act case against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
9 Jan 2017, 9:36 am by Lawrence B. Ebert
In other words, Copaxone should remain a $4 billion drug, annually.link to Pantagraph: http://www.pantagraph.com/business/investment/markets-and-stocks/factors-that-sent-teva-pharmaceutical-industries-ltd-sliding-in/article_74234eee-a5ec-5c58-a54b-82597151b1e6.htmlPatents covering "three per week" dosing were not at issue in the Supreme Court case of Teva Pharmaceuticals USA, Inc. v. [read post]
17 Apr 2014, 12:49 pm by Lyle Denniston
Teva Pharmaceuticals USA, Inc., the maker of a widely used drug for treating multiple sclerosis, told the Supreme Court on Thursday that it is willing to put aside promptly up to $500 million to cover marketing losses that generic competitors might have if Teva succeeds in keeping them on the sidelines for months with their lower-priced alternative versions of the drug. [read post]
14 Jul 2013, 9:23 pm by Patent Docs
• Defendants: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd. [read post]
22 May 2011, 8:41 pm by Patent Docs
Teva Pharamceuticals USA, Inc. 1:11-cv-00384; filed April 29, 2011 in the District Court of Delaware • Plainitffs: Abbott Products Inc.; Unimed Pharmaceuticals LLC; Besins Healthcare Inc. • Defendant: Teva Pharmaceuticals USA, Inc. [read post]
22 Jul 2018, 8:32 pm by Patent Docs
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
18 Aug 2013, 8:54 pm by Patent Docs
Teva Biopharmaceuticals USA, Inc. et al. 2:13-cv-04911; filed August 12, 2013 in the District Court of New Jersey • Plaintiffs: Amgen Inc.; Amgen Manufacturing, Limited • Defendants: Teva Biopharmaceuticals USA, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]